A 99-patient study confirms that a laparo-endoluminal approach reduces proton pump inhibitor medication use and significantly improves quality-of-life scores REDMOND, Wash – EndoGastric Solutions® today announced the publication of new clinical data confirming that concomitantly performed hiatal hernia (HH) repair and the Transoral Incisionless Fundoplication (TIF® 2.0) procedure using the EsophyX® device, is an effective […]
EndoGastric Solutions Closes Series I Financing at a Total of $45 Million
Participation of Accelmed, a leading medical device investor, validates the compelling market potential of the company’s EsophyX technology REDMOND, Wash. – May 28, 2019 – EndoGastric Solutions® today announced the closing of its Series I financing at a total of $45 million. Accelmed, a leading growth capital medical device investor, joined the round, which had […]
EndoGastric Solutions’ TIF 2.0 Procedure Highlighted in Multiple Sessions at DDW 2019
EGS to host DDW Product Theater session showcasing the evolution of TIF 2.0 procedure along with updates on concomitant hiatal hernia repair REDMOND, Wash. – EndoGastric Solutions® today announced that new data on the Transoral Incisionless Fundoplication (TIF® 2.0) procedure will be presented during multiple sessions at Digestive Disease Week® (DDW®) 2019. These data add […]
EndoGastric Solutions® Announces New Data Demonstrating pH Control Following TIF 2.0 and Hiatal Hernia Repair Procedures in GERD Patients
– 95% of patients achieved normal pH exposure levels following concomitant HHR and TIF 2.0 procedures – – GERD-related quality of life and reflux symptom scores also improved significantly – REDMOND, Wash. – EndoGastric Solutions today announced the publication of new clinical data demonstrating high rates of pH normalization and improved clinical outcomes in patients […]
- 1
- 2
- 3
- …
- 14
- Next Page »